{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:05:35Z","timestamp":1779944735764,"version":"3.53.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.psychres.2025.116689","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T05:25:42Z","timestamp":1755667542000},"page":"116689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A retrospective analysis of ketamine intravenous therapy for post-traumatic stress disorder in real-world care settings"],"prefix":"10.1016","volume":"352","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-7263","authenticated-orcid":false,"given":"Lynne Alison","family":"McInnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Mark","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6761-1832","authenticated-orcid":false,"given":"Emily","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116689_bib0029","first-page":"376","article-title":"Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial","author":"Abbar","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116689_bib0018","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-pharmtox-010818-021701","article-title":"The neurobiology and pharmacotherapy of posttraumatic stress disorder","volume":"59","author":"Abdallah","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"8","key":"10.1016\/j.psychres.2025.116689_bib0065","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41386-022-01266-9","article-title":"Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial","volume":"47","author":"Abdallah","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.psychres.2025.116689_bib0064","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00213-022-06123-7","article-title":"Great expectations: recommendations for improving the methodological rigor of psychedelic clinical trials","volume":"239","author":"Aday","year":"2022","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.psychres.2025.116689_bib0051","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11634","article-title":"Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression","volume":"79","author":"Albott","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2025.116689_bib0038","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1177\/0271678X221116477","article-title":"Evidence for the beneficial effect of ketamine in the treatment of patients with post-traumatic stress disorder: a systematic review and meta-analysis","volume":"42","author":"Albuquerque","year":"2022","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0003","first-page":"32","article-title":"Pharmacotherapy for post-traumatic stress disorder in combat veterans: focus on antidepressants and atypical antipsychotic agents","volume":"37","author":"Alexander","year":"2012","journal-title":"P T"},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0037","first-page":"22","article-title":"Effectiveness of ketamine for the treatment of post-traumatic stress disorder \u2013 a systematic review and meta-analysis","volume":"21","author":"Almeida","year":"2024","journal-title":"Clin. Neuropsychiatry"},{"key":"10.1016\/j.psychres.2025.116689_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105044","article-title":"Ketamine for post-traumatic stress disorders and its possible therapeutic mechanism","volume":"146","author":"Asim","year":"2021","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.psychres.2025.116689_bib0001","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13543784.2022.2035358","article-title":"Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine","volume":"31","author":"Averill","year":"2022","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0054","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jsp.2009.10.001","article-title":"An introduction to modern missing data analyses","volume":"48","author":"Baraldi","year":"2010","journal-title":"J. Sch. Psychol."},{"issue":"14","key":"10.1016\/j.psychres.2025.116689_bib0042","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2019.4064","article-title":"The evolving uses of \u201creal-world\u201d data","volume":"321","author":"Basch","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.psychres.2025.116689_bib0056","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2025.116689_bib0030","doi-asserted-by":"crossref","first-page":"e1927","DOI":"10.1002\/mpr.1927","article-title":"Montgomery\u2013\u00c5sberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: derivation, replication, and change over time during treatment with esketamine","volume":"31","author":"Borentain","year":"2022","journal-title":"Int. J. Methods Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/20008066.2023.2299124","article-title":"So how special is special K? A systematic review and meta-analysis of ketamine for PTSD RCTs","volume":"15","author":"Borgogna","year":"2024","journal-title":"Eur. J. Psychotraumatol."},{"issue":"4","key":"10.1016\/j.psychres.2025.116689_bib0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1176\/appi.ps.201900295","article-title":"Defining success in measurement-based care for depression: a comparison of common metrics","volume":"71","author":"Coley","year":"2020","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0057","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0004867416631828","article-title":"Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation","volume":"51","author":"Cusin","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0043","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12888-022-03789-3","article-title":"Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review","volume":"22","author":"Dai","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0022","doi-asserted-by":"crossref","DOI":"10.52965\/001c.25091","article-title":"Role of ketamine in the treatment of psychiatric disorders","volume":"9","author":"Derakhshanian","year":"2021","journal-title":"Health Psychol. Res."},{"issue":"7","key":"10.1016\/j.psychres.2025.116689_bib0033","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.euroneuro.2017.05.004","article-title":"The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes \u2013 results from a cross-sectional European multicenter study","volume":"27","author":"Dold","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116689_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.813103","article-title":"The multivariate effect of ketamine on PTSD: systematic review and meta-analysis","volume":"13","author":"Du","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2025.116689_bib0026","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116689_bib0027","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","article-title":"A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder","volume":"178","author":"Feder","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116689_bib0034","doi-asserted-by":"crossref","first-page":"141","DOI":"10.31887\/DCNS.2015.17.2\/jflory","article-title":"Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations","volume":"17","author":"Flory","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.psychres.2025.116689_bib0017","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neulet.2016.11.048","article-title":"Considering future pharmacotherapy for PTSD","volume":"649","author":"Friedman","year":"2017","journal-title":"Neurosci. lett."},{"key":"10.1016\/j.psychres.2025.116689_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109211","article-title":"Pharmacological strategies for post-traumatic stress disorder (PTSD): from animal to clinical studies","volume":"218","author":"Gasparyan","year":"2022","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.psychres.2025.116689_bib0032","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jts.22496","article-title":"Combat-related posttraumatic stress disorder and comorbid major depression in US Veterans: the role of deployment cycle adversity and social support","volume":"33","author":"Goetter","year":"2020","journal-title":"J. Trauma. Stress"},{"key":"10.1016\/j.psychres.2025.116689_bib0039","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jad.2023.04.141","article-title":"The effects of ketamine on symptoms of depression and anxiety in real-world care settings: a retrospective controlled analysis","volume":"335","author":"Hietamies","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0015","doi-asserted-by":"crossref","DOI":"10.3402\/ejpt.v7.31858","article-title":"PTSD: from neurobiology to pharmacological treatments","volume":"7","author":"Kelmendi","year":"2016","journal-title":"Eur. J. Psychotraumatol."},{"issue":"6","key":"10.1016\/j.psychres.2025.116689_bib0058","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116689_bib0031","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/15299732.2016.1237402","article-title":"Posttraumatic stress disorder in outpatients with depression: still a missed diagnosis","volume":"18","author":"Kostaras","year":"2017","journal-title":"J. Trauma Dissociation"},{"issue":"8","key":"10.1016\/j.psychres.2025.116689_bib0013","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1037\/tra0001197","article-title":"Posttraumatic stress disorder and depression residual symptoms among veterans and service members who completed a 3-week cognitive processing therapy-based intensive treatment program","volume":"15","author":"Kovacevic","year":"2023","journal-title":"Psychol. Trauma: Theory Res. Pract. Policy"},{"issue":"9","key":"10.1016\/j.psychres.2025.116689_bib0049","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.psychres.2025.116689_bib0053","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1503\/cmaj.112004","article-title":"Enhancing the clinical utility of depression screening","volume":"184","author":"Kroenke","year":"2012","journal-title":"Cmaj"},{"issue":"3","key":"10.1016\/j.psychres.2025.116689_bib0044","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","article-title":"Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials","volume":"72","author":"Kryst","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.psychres.2025.116689_bib0005","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.biopsych.2017.03.007","article-title":"It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD psychopharmacology working group","volume":"82","author":"Krystal","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116689_bib0014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/tra0000384","article-title":"Residual symptoms following empirically supported treatment for PTSD","volume":"11","author":"Larsen","year":"2019","journal-title":"Psychol. Trauma: Theory Res. Pract. Policy"},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0007","article-title":"Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis","volume":"11","author":"Lewis","year":"2020","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.psychres.2025.116689_bib0055","series-title":"Developmental Psychopathology: Vol. 1. Theory and Method","first-page":"760","article-title":"Missing data","author":"Little","year":"2016"},{"issue":"5","key":"10.1016\/j.psychres.2025.116689_bib0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/appi.ajp.2014.14070908","article-title":"Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD","volume":"172","author":"Markowitz","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116689_bib0048","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1037\/pas0001098","article-title":"Reliable and clinically significant change in the clinician-administered PTSD scale for DSM-5 and PTSD checklist for DSM-5 among male veterans","volume":"34","author":"Marx","year":"2022","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.psychres.2025.116689_bib0028","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jad.2021.12.097","article-title":"A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings","volume":"301","author":"McInnes","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116689_bib0041","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jad.2024.02.033","article-title":"Embracing pragmatism for ketamine insurance coverage: leveraging real-world evidence","volume":"352","author":"McInnes","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.psychres.2025.116689_bib0021","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/phar.2707","article-title":"Safety and effectiveness of NMDA receptor antagonists for depression: a multidisciplinary review","volume":"42","author":"Moore","year":"2022","journal-title":"Pharmacother.: J. Hum. Pharmacol. Drug Ther."},{"issue":"10","key":"10.1016\/j.psychres.2025.116689_bib0023","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2025.116689_bib0024","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jamapsychiatry.2022.1074","article-title":"Evaluation of the trajectory of depression severity with ketamine and esketamine treatment in a clinical setting","volume":"79","author":"Nikayin","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0035","first-page":"64","article-title":"Longitudinal study of PTSD and depression in a war-exposed sample \u2013 comorbidity increases distress and suicide risk","volume":"3","author":"Pejuskovic","year":"2020","journal-title":"Glob. Psychiatry Arch."},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0040","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.23m14984","article-title":"Clinical outcomes of intravenous ketamine treatment for depression in the VA health system","volume":"85","author":"Pfeiffer","year":"2024","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2025.116689_bib0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2025.116689_bib0059","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.janxdis.2011.08.003","article-title":"Understanding the relationship between co-occurring PTSD and MDD: symptom severity and affect","volume":"25","author":"Post","year":"2011","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.psychres.2025.116689_bib0016","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.5c00335","article-title":"Neurochemical, neurocircuitry, and psychopathological mechanisms of PTSD: emerging pharmacotherapies and clinical perspectives","author":"Prajapati","year":"2025","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0061","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jagp.2015.11.001","article-title":"Post-traumatic stress disorder across the adult lifespan: findings from a nationally representative survey","volume":"24","author":"Reynolds","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116689_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108365","article-title":"PTSD improvement and substance use disorder treatment utilization in veterans: evidence from medical record data","volume":"218","author":"Salas","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.psychres.2025.116689_bib0025","first-page":"632","article-title":"Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression","volume":"36","author":"Salloum","year":"2019","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.psychres.2025.116689_bib0008","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jts.22556","article-title":"A systematic review of intensive empirically supported treatments for posttraumatic stress disorder","volume":"33","author":"Sciarrino","year":"2020","journal-title":"J. Trauma. Stress"},{"issue":"8","key":"10.1016\/j.psychres.2025.116689_bib0063","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2025.116689_bib0009","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.2015.8370","article-title":"Psychotherapy for military-related PTSD: a review of randomized clinical trials","volume":"314","author":"Steenkamp","year":"2015","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.psychres.2025.116689_bib0010","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jama.2019.20825","article-title":"First-line psychotherapies for military-related PTSD","volume":"323","author":"Steenkamp","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.psychres.2025.116689_bib0012","article-title":"Comparing treatments for post-traumatic stress disorder \u2013 a systematic review","volume":"68","author":"Storm","year":"2021","journal-title":"Dan. Med. J."},{"issue":"2","key":"10.1016\/j.psychres.2025.116689_bib0011","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jts.22915","article-title":"Predictors of treatment completion in group psychotherapy for male veterans with posttraumatic stress disorder","volume":"36","author":"Stoycos","year":"2023","journal-title":"J. Trauma. Stress"},{"issue":"1","key":"10.1016\/j.psychres.2025.116689_bib0020","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1192\/bjo.2021.1061","article-title":"Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review","volume":"8","author":"Walsh","year":"2021","journal-title":"BJPsych Open"},{"key":"10.1016\/j.psychres.2025.116689_bib0046","unstructured":"Weathers, F.W., Litz, B.T., Keane, T.M., Palmieri, P.A., Marx, B.P., & Schnurr P.P., 2013. The PTSD checklist for dsm-5.(pcl-5)."},{"issue":"3","key":"10.1016\/j.psychres.2025.116689_bib0002","article-title":"Pharmacotherapy for post traumatic stress disorder (PTSD)","author":"Williams","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.psychres.2025.116689_bib0004","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00004714-200204000-00013","article-title":"Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder","volume":"22","author":"Zohar","year":"2002","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125003373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125003373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:48:01Z","timestamp":1779943681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125003373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":64,"alternative-id":["S0165178125003373"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116689","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective analysis of ketamine intravenous therapy for post-traumatic stress disorder in real-world care settings","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116689"}}